Iambic Therapeutics’ $50 Million Series B Extension Financing

Wilson Sonsini Goodrich & Rosati advised Iambic Therapeutics on the transaction.Iambic Therapeutics (Iambic), a clinical-stage biotechnology company, announced the closing of an oversubscribed $50 million extension,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now